Xcout Intel
Ractigen Therapeutics
Ractigen Therapeutics is a clinical-stage biopharmaceutical company headquartered in China that specializes in pioneering siRNA therapies designed to silence target genes.
Subscribe to see Ractigen Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ractigen Therapeutics at a glance
Ractigen Therapeutics is a healthcare company headquartered in China. Its most recent funding round, Series A+, raised $30M in January 2022. Xcout tracks 10 named people at Ractigen Therapeutics, including Moorim Kang (CTO).
Ractigen Therapeutics leadership
- Moorim KangCTO
- Lorenzo XieChief Strategy Officer
- Long-Cheng LiCO-FOUNDER, PRESIDENT & CEO
- Kevin LinVice President, Preclinical Development
- Shawn ZhangVICE PRESIDENT, CLINICAL DEVELOPMENT
- Feng FangBoard Member
4 more named people on record for Ractigen Therapeutics, with roles, board committees and tenure — see the full roster →
Ractigen Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A+ | $30M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Get Ractigen Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ractigen Therapeutics in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access